Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03057119 · ClinicalTrials.gov registry record · NA
Feasibility of SBIRT-PN
A NA study, sponsored by Florida State University.
- Completed
- Registry status
- NA
- Development phase
- 86
- Enrollment target
NCT03057119 is a NA study that has completed, run by Florida State University. The registered enrollment target is 86 participants.
The verdict
NCT03057119, a NA study, has completed, sponsored by Florida State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 86 participants
- Enrollment target
Study Summary
Substance misuse is a common problem among HIV+ individuals. Research suggests that a Screening, Brief Intervention, and Treatment (SBIRT) model can be effective in reducing substance misuse in the general older adult population; however these findings have not been verified in the more vulnerable HIV+ older adult population. The present study seeks to address the problem of substance misuse in older HIV+ adults by piloting a SBIRT model for older HIV+ adults in a in a primary care setting. Individual reductions in alcohol and drug use can have significant effects on public health and safety when observed over a large population at risk for substance use problems. With wider dissemination statewide, a relatively low-cost intervention such as SBIRT could offer demonstrated benefits in this population.
Interventions
- BEHAVIORAL Psycho-educational content (5 Minutes)
- BEHAVIORAL Readiness Assessment (10 minutes)
- BEHAVIORAL Goal-Setting (5 minutes)
- BEHAVIORAL Identifying and prioritizing needs (5 minutes)
- BEHAVIORAL Explanation of Peer Navigator and Session wrap (5 minutes)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 86 participants |
| Start Date | 2018-02-12 |
| Est. Completion | 2022-03-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03057119
The ClinicalTrials.gov registry entry for NCT03057119 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 86 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Florida State University, which has 219 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Psycho-educational content (5 Minutes) is the first listed.
NCT03057119 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03057119 about?
NCT03057119 is a clinical study titled "Feasibility of SBIRT-PN". Substance misuse is a common problem among HIV+ individuals. Research suggests that a Screening, Brief Intervention, and Treatment (SBIRT) model can be effective in reducing substance misuse in the general older adult population; however these findings have not been verified in the more vulnerable H...
What is the current status of trial NCT03057119?
This trial is currently completed. It is a NA study. The enrollment target is 86 participants. The study started on 2018-02-12. Estimated completion is 2022-03-31.
What interventions are being tested in trial NCT03057119?
The interventions under investigation include: Psycho-educational content (5 Minutes) (BEHAVIORAL), Readiness Assessment (10 minutes) (BEHAVIORAL), Goal-Setting (5 minutes) (BEHAVIORAL), Identifying and prioritizing needs (5 minutes) (BEHAVIORAL), Explanation of Peer Navigator and Session wrap (5 minutes) (BEHAVIORAL).
Who is sponsoring clinical trial NCT03057119?
This trial is sponsored by Florida State University, which has 219 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.